Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-06-26

FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for doxepin hydrochloride from Lannett Company, Inc., authorizing changes to an already approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DOXEPIN HYDROCHLORIDE (doxepin hydrochloride)

Snippet

SUPPL AP for DOXEPIN HYDROCHLORIDE (DOXEPIN HYDROCHLORIDE)